Ensysce Biosciences regains compliance with Nasdaq equity requirement on June 13

Ensysce Biosciences, Inc.

Received formal notice from Nasdaq that it now meets the equity requirement under Listing Rule 5550(b)(1).
The Nasdaq Hearings Panel matter concerning listing compliance has been closed.
Ensysce common stock (ENSC) will continue trading on the Nasdaq Capital Market.
Company cautioned that future compliance with all Nasdaq requirements is not guaranteed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.